LCTX

1.63

2.52% 0.04

Pre-mercato: 1.68 0.05 +3.07%

Lineage Cell Therapeutics Inc (LCTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.59

Aprire:

$1.58

Volume 24 ore:

1.80M

Relative Volume:

1.58

Capitalizzazione di mercato:

$406.01M

Reddito:

$14.56M

Utile/perdita netta:

$-63.37M

Rapporto P/E:

-5.857

EPS:

-0.2783

Flusso di cassa netto:

$-19.44M

1 W Prestazione:

+5.84%

1M Prestazione:

+1.24%

6M Prestazione:

-9.94%

1 anno Prestazione:

+280.04%

Intervallo 1D:

$1.58

$1.685

Intervallo di 1 settimana:

$1.45

$1.685

Portata 52W:

$0.40

$2.09

Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile

Nome

Lineage Cell Therapeutics Inc

Settore

Healthcare (1112)

Industria

Biotechnology (621)

Telefono

510-871-4188

Indirizzo

2173 Salk Avenue, Suite 200, Carlsbad, CA

Dipendente

Cinguettio

@LineageCell

Prossima data di guadagno

2025-03-10

Ultimi documenti SEC

LCTX's Discussions on Twitter

Compare LCTX vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LCTX Lineage Cell Therapeutics Inc	1.63	396.05M	14.56M	-63.37M	-19.44M	-0.2783
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-20	Iniziato	Craig Hallum	Buy
2022-11-02	Iniziato	Robert W. Baird	Outperform
2022-06-14	Iniziato	B. Riley Securities	Buy
2021-08-19	Iniziato	Noble Capital Markets	Outperform
2021-03-31	Iniziato	Cantor Fitzgerald	Overweight

Lineage Cell Therapeutics Inc Borsa (LCTX) Ultime notizie

Apr 15, 2026

Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration - simplywall.st

Apr 15, 2026

Apr 14, 2026

Lineage Announces Formation of Scientific Advisory Board - BioSpace

Apr 14, 2026

Apr 13, 2026

Lineage Cell Therapeutics (LCTX) Establishes New Scientific Advi - GuruFocus

Apr 13, 2026

Lineage Cell Therapeutics forms advisory board, names clinical head By Investing.com - Investing.com Australia

Apr 13, 2026

Lineage Cell Therapeutics forms advisory board, names clinical head - Investing.com

Apr 13, 2026

Apr 12, 2026

Guidance Update: Can Lineage Cell Therapeutics Inc maintain sales growth2026 Market Trends & Reliable Intraday Trade Alerts - baoquankhu1.vn

Apr 12, 2026

Apr 11, 2026

Tech Rally: Is Lineage Cell Therapeutics Inc still a buy after recent gains2026 Stock Rankings & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Apr 11, 2026

If You Invested $1,000 in Lineage Cell The (LCTX) - Stock Titan

Apr 11, 2026

Apr 10, 2026

Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells - PR Newswire

Apr 10, 2026

Biotechs Racing to Translate Longevity Science Into Real TherapiesAnd One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells - The Malaysian Reserve

Apr 10, 2026

Apr 09, 2026

Lineage Cell Therapeutics launches COR1 for corneal diseases amid rising FECD prevalence - Traders Union

Apr 09, 2026

Apr 08, 2026

Q4 2025 Lineage Cell Therapeutics Inc Earnings Call Transcript - GuruFocus

Apr 08, 2026

Apr 07, 2026

Pharma News: Can Lineage Cell Therapeutics Inc reach resistance levels soon2026 Technical Overview & AI Enhanced Trading Signals - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Lineage Cell Therapeutics pushes scalable platforms to address drug discovery complexity - Traders Union

Apr 02, 2026

Apr 01, 2026